Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Chronic Heart Failure

Free Subscription Articles published in Circ Res Retrieve available abstracts of 82 articles: HTML format

Single Articles

March 2023
1. CANNAVO A, Jun S, Rengo G, Marzano F, et al
   beta3AR-Dependent BDNF (Brain-Derived Neurotrophic Factor) Generation Limits Chronic Postischemic Heart Failure.
   Circ Res. 2023 Mar 8. doi: 10.1161/CIRCRESAHA.122.321583.
   PubMed     Abstract available
   
   
   
2. HUGHES A, Shandhi MMH, Master H, Dunn J, et al
   Wearable Devices in Cardiovascular Medicine.
   Circ Res. 2023;132:652-670.
   PubMed     Abstract available
   
   
   February 2023
3. YE B, Zhou H, Chen Y, Luo W, et al
   USP25 Ameliorates Pathological Cardiac Hypertrophy by Stabilizing SERCA2a in Cardiomyocytes.
   Circ Res. 2023;132:465-480.
   PubMed     Abstract available
   
   
   
4. SAWICKI KT, De Jesus A, Ardehali H
   Iron Metabolism in Cardiovascular Disease: Physiology, Mechanisms, and Therapeutic Targets.
   Circ Res. 2023;132:379-396.
   PubMed     Abstract available
   
   
   
5. PI H, Xia L, Ralph DD, Rayner SG, et al
   Metabolomic Signatures Associated With Pulmonary Arterial Hypertension Outcomes.
   Circ Res. 2023;132:254-266.
   PubMed     Abstract available
   
   
   January 2023
6. EL JAMAL N, Lordan R, Teegarden SL, Grosser T, et al
   The Circadian Biology of Heart Failure.
   Circ Res. 2023;132:223-237.
   PubMed     Abstract available
   
   
   
7. RUBINO M, Travers JG, Headrick AL, Enyart BT, et al
   Inhibition of Eicosanoid Degradation Mitigates Fibrosis of the Heart.
   Circ Res. 2023;132:10-29.
   PubMed     Abstract available
   
   
   December 2022
8. LI Z, Xia H, Sharp TE 3rd, LaPenna KB, et al
   Hydrogen Sulfide Modulates Endothelial-Mesenchymal Transition in Heart Failure.
   Circ Res. 2022 Dec 28. doi: 10.1161/CIRCRESAHA.122.321326.
   PubMed     Abstract available
   
   
   
9. DENG B, Zhang Y, Zhu C, Wang Y, et al
   Divergent Actions of Myofibroblast and Myocyte beta(2)-Adrenoceptor in Heart Failure and Fibrotic Remodeling.
   Circ Res. 2022 Dec 2. doi: 10.1161/CIRCRESAHA.122.321816.
   PubMed    
   
   
   October 2022
10. WU X, Liu H, Brooks A, Xu S, et al
    SIRT6 Mitigates Heart Failure With Preserved Ejection Fraction in Diabetes.
    Circ Res. 2022 Oct 24. doi: 10.1161/CIRCRESAHA.121.318988.
    PubMed     Abstract available
    
    
    September 2022
11. 
    Correction to: Mitochondrial H2S Regulates BCAA Catabolism in Heart Failure.
    Circ Res. 2022;131:e101.
    PubMed    
    
    
    
12. ZHANG J, Gutierrez-Lara EJ, Liang Y, Sheikh F, et al
    Functions Beyond the Editor's I in Regulating Cardiac Innate Immunity and Heart Failure.
    Circ Res. 2022;131:598-600.
    PubMed    
    
    
    
13. UMBARKAR P, Tousif S, Singh AP, Anderson JC, et al
    Fibroblast GSK-3alpha Promotes Fibrosis via RAF-MEK-ERK Pathway in the Injured Heart.
    Circ Res. 2022;131:620-636.
    PubMed     Abstract available
    
    
    
14. GARCIA-GONZALEZ C, Dieterich C, Maroli G, Wiesnet M, et al
    ADAR1 Prevents Autoinflammatory Processes in the Heart Mediated by IRF7.
    Circ Res. 2022;131:580-597.
    PubMed     Abstract available
    
    
    
15. TIAN C, Gao L, Rudebush TL, Yu L, et al
    Extracellular Vesicles Regulate Sympatho-Excitation by Nrf2 in Heart Failure.
    Circ Res. 2022 Sep 13:101161CIRCRESAHA122320916.
    PubMed     Abstract available
    
    
    August 2022
16. 
    Correction to: Heart Failure with Preserved Ejection Fraction: Heterogeneous Syndrome, Diverse Preclinical Models.
    Circ Res. 2022;131:e100.
    PubMed    
    
    
    July 2022
17. DOIRON JE, Lefer DJ
    Leveraging Adipocyte-Cardiomyocyte Signaling to Treat Ischemic Heart Failure.
    Circ Res. 2022;131:165-167.
    PubMed    
    
    
    June 2022
18. WANG X, Zhang G, Dasgupta S, Niewold EL, et al
    ATF4 Protects the Heart From Failure by Antagonizing Oxidative Stress.
    Circ Res. 2022;131:91-105.
    PubMed     Abstract available
    
    
    
19. LI Z, Xia H, Sharp TE 3rd, LaPenna KB, et al
    Mitochondrial H2S Regulates BCAA Catabolism in Heart Failure.
    Circ Res. 2022 Jun 14:101161CIRCRESAHA121319817.
    PubMed     Abstract available
    
    
    
20. PILZ PM, Ward JE, Chang WT, Kiss A, et al
    Large and Small Animal Models of Heart Failure With Reduced Ejection Fraction.
    Circ Res. 2022;130:1888-1905.
    PubMed     Abstract available
    
    
    
21. ROH J, Hill JA, Singh A, Valero-Munoz M, et al
    Heart Failure With Preserved Ejection Fraction: Heterogeneous Syndrome, Diverse Preclinical Models.
    Circ Res. 2022;130:1906-1925.
    PubMed     Abstract available
    
    
    
22. BUGGER H, Byrne NJ, Abel ED
    Animal Models of Dysregulated Cardiac Metabolism.
    Circ Res. 2022;130:1965-1993.
    PubMed     Abstract available
    
    
    May 2022
23. MICHEL T, Nougue H, Cartailler J, Lefevre G, et al
    proANP Metabolism Provides New Insights Into Sacubitril/Valsartan Mode of Action.
    Circ Res. 2022;130:e44-e57.
    PubMed     Abstract available
    
    
    
24. ZHU D, Zhang Z, Zhao J, Liu D, et al
    Targeting Adiponectin Receptor 1 Phosphorylation Against Ischemic Heart Failure.
    Circ Res. 2022 May 25:101161CIRCRESAHA121319976.
    PubMed     Abstract available
    
    
    
25. PATEL KP, Katsurada K, Zheng H
    Cardiorenal Syndrome: The Role of Neural Connections Between the Heart and the Kidneys.
    Circ Res. 2022;130:1601-1617.
    PubMed     Abstract available
    
    
    
26. LIU J, Li W, Deng KQ, Tian S, et al
    The E3 Ligase TRIM16 Is a Key Suppressor of Pathological Cardiac Hypertrophy.
    Circ Res. 2022;130:1586-1600.
    PubMed     Abstract available
    
    
    
27. TOMA A, Dos Santos C, Burzynska B, Gora M, et al
    Diversity in the Expressed Genomic Host Response to Myocardial Infarction.
    Circ Res. 2022 May 9:101161CIRCRESAHA121318391.
    PubMed    
    
    
    April 2022
28. 
    Correction to: Heart Failure Subtypes and Cardiomyopathies in Women.
    Circ Res. 2022;130:e25.
    PubMed    
    
    
    
29. BRITTAIN EL, Hemnes AR
    Introduction to Review Series on Pulmonary Vascular Disease and Right Ventricular Heart Failure.
    Circ Res. 2022;130:1362-1364.
    PubMed    
    
    
    
30. HUSTON JH, Shah SJ
    Understanding the Pathobiology of Pulmonary Hypertension Due to Left Heart Disease.
    Circ Res. 2022;130:1382-1403.
    PubMed     Abstract available
    
    
    
31. ALENEZI F, Covington TA, Mukherjee M, Mathai SC, et al
    Novel Approaches to Imaging the Pulmonary Vasculature and Right Heart.
    Circ Res. 2022;130:1445-1465.
    PubMed     Abstract available
    
    
    
32. BOUCHERAT O, Agrawal V, Lawrie A, Bonnet S, et al
    The Latest in Animal Models of Pulmonary Hypertension and Right Ventricular Failure.
    Circ Res. 2022;130:1466-1486.
    PubMed     Abstract available
    
    
    
33. 
    Correction to: The Cancer Therapy-Related Clonal Hematopoiesis Driver Gene Ppm1d Promotes Inflammation and Non-Ischemic Heart Failure in Mice.
    Circ Res. 2022;130:e23.
    PubMed    
    
    
    
34. MESUBI OO, Anderson ME
    Heart Failure and Atrial Fibrillation-Chicken or Egg?
    Circ Res. 2022;130:1011-1013.
    PubMed    
    
    
    March 2022
35. WANG J, Shi Q, Wang Y, Dawson LW, et al
    Gene Therapy With the N-Terminus of Junctophilin-2 Improves Heart Failure in Mice.
    Circ Res. 2022 Mar 23:CIRCRESAHA121320680. doi: 10.1161/CIRCRESAHA.121.320680.
    PubMed     Abstract available
    
    
    
36. 
    Correction to: Heart Failure Subtypes and Cardiomyopathies in Women.
    Circ Res. 2022;130:e21.
    PubMed    
    
    
    
37. STACHOWSKI-DOLL MJ, Papadaki M, Martin TG, Ma W, et al
    GSK-3beta Localizes to the Cardiac Z-Disc to Maintain Length Dependent Activation.
    Circ Res. 2022;130:871-886.
    PubMed     Abstract available
    
    
    
38. YAO Y, Li F, Zhang M, Jin L, et al
    Targeting CaMKII-delta9 Ameliorates Cardiac Ischemia/Reperfusion Injury by Inhibiting Myocardial Inflammation.
    Circ Res. 2022;130:887-903.
    PubMed     Abstract available
    
    
    
39. MA K, Yang J, Shao Y, Li P, et al
    Therapeutic and Prognostic Significance of Arachidonic Acid in Heart Failure.
    Circ Res. 2022 Mar 8:CIRCRESAHA121320548. doi: 10.1161/CIRCRESAHA.121.320548.
    PubMed     Abstract available
    
    
    February 2022
40. DEFILIPPIS EM, Beale A, Martin T, Agarwal A, et al
    Heart Failure Subtypes and Cardiomyopathies in Women.
    Circ Res. 2022;130:436-454.
    PubMed     Abstract available
    
    
    
41. KECELI G, Gupta A, Sourdon J, Gabr R, et al
    Mitochondrial Creatine Kinase Attenuates Pathologic Remodeling in Heart Failure.
    Circ Res. 2022 Feb 3:CIRCRESAHA121319648. doi: 10.1161/CIRCRESAHA.121.319648.
    PubMed     Abstract available
    
    
    January 2022
42. SOSSALLA S, Bers DM
    Neuron-Restrictive Silencer Factor Limits Myocyte GalphaO Expression and Is Protective in Heart Failure Progression.
    Circ Res. 2022;130:249-251.
    PubMed    
    
    
    
43. SHEA S, Blaha MJ
    Long-Term Risk Prediction for Heart Failure, Disparities, and Early Prevention.
    Circ Res. 2022;130:210-212.
    PubMed    
    
    
    
44. INAZUMI H, Kuwahara K, Nakagawa Y, Kuwabara Y, et al
    NRSF-GNAO1 Pathway Contributes to the Regulation of Cardiac Ca(2+) Homeostasis.
    Circ Res. 2022;130:234-248.
    PubMed     Abstract available
    
    
    December 2021
45. KHAN SS, Ning H, Allen NB, Carnethon M, et al
    Development and Validation of A Long-Term Incident Heart Failure Risk Model.
    Circ Res. 2021 Dec 10. doi: 10.1161/CIRCRESAHA.121.319595.
    PubMed     Abstract available
    
    
    October 2021
46. 
    Correction to: The Cancer Therapy-Related Clonal Hematopoiesis Driver Gene Ppm1d Promotes Inflammation and Non-Ischemic Heart Failure in Mice.
    Circ Res. 2021;129:e201.
    PubMed    
    
    
    
47. SOETKAMP D, Gallet R, Parker SJ, Holewinski R, et al
    Myofilament Phosphorylation in Stem Cell Treated Diastolic Heart Failure.
    Circ Res. 2021 Oct 13. doi: 10.1161/CIRCRESAHA.119.316311.
    PubMed     Abstract available
    
    
    September 2021
48. WANG Y, Zhao M, Shi Q, Xu B, et al
    Monoamine Oxidases Desensitize Intracellular beta1AR Signaling in Heart Failure.
    Circ Res. 2021 Sep 17. doi: 10.1161/CIRCRESAHA.121.319546.
    PubMed    
    
    
    August 2021
49. RONG J, Tao X, Lin Y, Zheng H, et al
    Loss of Hepatic Angiotensinogen Attenuates Sepsis-Induced Myocardial Dysfunction.
    Circ Res. 2021;129:547-564.
    PubMed     Abstract available
    
    
    July 2021
50. YURA Y, Miura-Yura E, Katanasaka Y, Min KD, et al
    The Cancer Therapy-Related Clonal Hematopoiesis Driver Gene Ppm1d Promotes Inflammation and Non-Ischemic Heart Failure in Mice.
    Circ Res. 2021 Jul 28. doi: 10.1161/CIRCRESAHA.121.319314.
    PubMed     Abstract available
    
    
    
51. PADULA SL, Yutzey KE
    Epigenetic Regulation of Heart Failure: Cell Type Matters.
    Circ Res. 2021;129:414-416.
    PubMed    
    
    
    June 2021
52. HUO JL, Jiao L, An Q, Chen X, et al
    Myofibroblast Deficiency of LSD1 Alleviates TAC-Induced Heart Failure.
    Circ Res. 2021 Jun 3. doi: 10.1161/CIRCRESAHA.120.318149.
    PubMed     Abstract available
    
    
    
53. GLASENAPP A, Derlin K, Gutberlet M, Hess A, et al
    Molecular Imaging of Inflammation and Fibrosis in Pressure Overload Heart Failure.
    Circ Res. 2021 Jun 2. doi: 10.1161/CIRCRESAHA.120.318539.
    PubMed     Abstract available
    
    
    May 2021
54. AKAR FG, Young LH
    NAD Repletion Therapy: A Silver Bullet for HFpEF?
    Circ Res. 2021;128:1642-1645.
    PubMed    
    
    
    
55. RURIK JG, Aghajanian H, Epstein JA
    Immune Cells and Immunotherapy for Cardiac Injury and Repair.
    Circ Res. 2021;128:1766-1779.
    PubMed     Abstract available
    
    
    
56. BURKE RM, Dirkx RA Jr, Quijada P, Lighthouse JK, et al
    Prevention of Fibrosis and Pathological Cardiac Remodeling by Salinomycin.
    Circ Res. 2021;128:1663-1678.
    PubMed     Abstract available
    
    
    
57. FAN J, Li H, Xie R, Zhang X, et al
    LncRNA ZNF593-AS Alleviates Contractile Dysfunction in Dilated Cardiomyopathy.
    Circ Res. 2021;128:1708-1723.
    PubMed     Abstract available
    
    
    
58. ROGER VL
    Epidemiology of Heart Failure: A Contemporary Perspective.
    Circ Res. 2021;128:1421-1434.
    PubMed     Abstract available
    
    
    
59. NJOROGE JN, Teerlink JR
    Pathophysiology and Therapeutic Approaches to Acute Decompensated Heart Failure.
    Circ Res. 2021;128:1468-1486.
    PubMed     Abstract available
    
    
    
60. LOPASCHUK GD, Karwi QG, Tian R, Wende AR, et al
    Cardiac Energy Metabolism in Heart Failure.
    Circ Res. 2021;128:1487-1513.
    PubMed     Abstract available
    
    
    
61. HAHN VS, Zhang KW, Sun L, Narayan V, et al
    Heart Failure With Targeted Cancer Therapies: Mechanisms and Cardioprotection.
    Circ Res. 2021;128:1576-1593.
    PubMed     Abstract available
    
    
    
62. MANN DL, Felker GM
    Mechanisms and Models in Heart Failure: A Translational Approach.
    Circ Res. 2021;128:1435-1450.
    PubMed     Abstract available
    
    
    
63. PAULUS WJ, Zile MR
    From Systemic Inflammation to Myocardial Fibrosis: The Heart Failure With Preserved Ejection Fraction Paradigm Revisited.
    Circ Res. 2021;128:1451-1467.
    PubMed     Abstract available
    
    
    
64. MANN DL
    Heart Failure 2021: A Compendium of Translational Success.
    Circ Res. 2021;128:1419-1420.
    PubMed    
    
    
    
65. BURKHOFF D, Topkara VK, Sayer G, Uriel N, et al
    Reverse Remodeling With Left Ventricular Assist Devices.
    Circ Res. 2021;128:1594-1612.
    PubMed     Abstract available
    
    
    April 2021
66. BLASER MC, Kraler S, Luscher TF, Aikawa E, et al
    Multi-Omics Approaches to Define Calcific Aortic Valve Disease Pathogenesis.
    Circ Res. 2021;128:1371-1397.
    PubMed     Abstract available
    
    
    
67. TONG D, Schiattarella GG, Jiang N, Altamirano F, et al
    NAD(+) Repletion Reverses Heart Failure with Preserved Ejection Fraction.
    Circ Res. 2021 Apr 22. doi: 10.1161/CIRCRESAHA.120.317046.
    PubMed     Abstract available
    
    
    
68. BOUTOUYRIE P, Chowienczyk P, Humphrey JD, Mitchell GF, et al
    Arterial Stiffness and Cardiovascular Risk in Hypertension.
    Circ Res. 2021;128:864-886.
    PubMed     Abstract available
    
    
    February 2021
69. CHEN K, Wang S, Sun QW, Zhang B, et al
    Klotho Deficiency Causes Heart Aging via Impairing the Nrf2-GR Pathway.
    Circ Res. 2021;128:492-507.
    PubMed     Abstract available
    
    
    
70. MUSTROPH J, Sag CM, Bahr F, Schmidtmann AL, et al
    Loss of CASK Accelerates Heart Failure Development.
    Circ Res. 2021 Feb 17. doi: 10.1161/CIRCRESAHA.120.318170.
    PubMed     Abstract available
    
    
    
71. TAEGTMEYER H
    Heart Failure in Diabetes: Still a Vexing Problem.
    Circ Res. 2021;128:358-359.
    PubMed    
    
    
    
72. MANGNER N, Garbade J, Heyne E, van den Berg M, et al
    Molecular Mechanisms of Diaphragm Myopathy in Humans with Severe Heart Failure.
    Circ Res. 2021 Feb 1. doi: 10.1161/CIRCRESAHA.120.318060.
    PubMed     Abstract available
    
    
    
73. LIU T, Yang N, Sidor A, O'Rourke B, et al
    MCU Overexpression Rescues Inotropy and Reverses Heart Failure by Reducing SR Ca(2+) Leak.
    Circ Res. 2021 Feb 1. doi: 10.1161/CIRCRESAHA.120.318562.
    PubMed     Abstract available
    
    
    January 2021
74. EVANS MA, Walsh K
    A Single-Cell Analysis of DNMT3A-Mediated Clonal Hematopoiesis in Heart Failure.
    Circ Res. 2021;128:229-231.
    PubMed    
    
    
    
75. DENG Y, Xie M, Li Q, Xu X, et al
    Targeting Mitochondria-Inflammation Circuit by beta-Hydroxybutyrate Mitigates HFpEF.
    Circ Res. 2021;128:232-245.
    PubMed     Abstract available
    
    
    
76. PERESTRELO AR, Silva AC, Oliver-De La Cruz J, Martino F, et al
    Multiscale Analysis of Extracellular Matrix Remodeling in the Failing Heart.
    Circ Res. 2021;128:24-38.
    PubMed     Abstract available
    
    
    
77. PAPA A, Kushner J, Hennessey JA, Katchman AN, et al
    Adrenergic CaV1.2 Activation via Rad Phosphorylation Converges at alpha1C I-II Loop.
    Circ Res. 2021;128:76-88.
    PubMed     Abstract available
    
    
    December 2020
78. WITTENBECHER C, Eichelmann F, Toledo E, Guasch-Ferre M, et al
    Lipid Profiles and Heart Failure Risk: Results from Two Prospective Studies.
    Circ Res. 2020 Dec 4. doi: 10.1161/CIRCRESAHA.120.317883.
    PubMed     Abstract available
    
    
    November 2020
79. ABPLANALP WT, Cremer S, John D, Hoffmann J, et al
    Clonal Hematopoiesis-Driver DNMT3A Mutations Alter Immune Cells in Heart Failure.
    Circ Res. 2020 Nov 6. doi: 10.1161/CIRCRESAHA.120.317104.
    PubMed     Abstract available
    
    
    July 2020
80. SHOEMAKER MB, Roden DM
    Atrial Fibrillation Is a Complex Trait: Very Complex.
    Circ Res. 2020;127:244-246.
    PubMed    
    
    
    May 2020
81. MARTINS-MARQUES T, Catarino S, Goncalves A, Miranda-Silva D, et al
    EHD1 Modulates Cx43 Gap Junction Remodeling Associated With Cardiac Diseases.
    Circ Res. 2020;126:e97-e113.
    PubMed     Abstract available
    
    
    March 2020
82. JOLY JM, Tallaj JA
    The Heart of the (Gray) Matter Is not Black and White.
    Circ Res. 2020;126:765-766.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: